Follow
John H. Van Drie
John H. Van Drie
Van Drie Research LLC
Verified email at vandrieresearch.com - Homepage
Title
Cited by
Cited by
Year
Design, Activity, and 2.8 Å Crystal Structure of a C2 Symmetric Inhibitor Complexed to HIV-1 Protease
J Erickson, DJ Neidhart, J VanDrie, DJ Kempf, XC Wang, DW Norbeck, ...
Science 249 (4968), 527-533, 1990
7461990
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
LM Lasko, CG Jakob, RP Edalji, W Qiu, D Montgomery, EL Digiammarino, ...
Nature 550 (7674), 128-132, 2017
3942017
Structure− activity landscape index: identifying and quantifying activity cliffs
R Guha, JH Van Drie
Journal of chemical information and modeling 48 (3), 646-658, 2008
3022008
ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional …
JH Van Drie, D Weininger, YC Martin
Journal of Computer-Aided Molecular Design 3 (3), 225-251, 1989
2571989
Navigating structure–activity landscapes
J Bajorath, L Peltason, M Wawer, R Guha, MS Lajiness, JH Van Drie
Drug discovery today 14 (13-14), 698-705, 2009
1742009
Computer-aided drug design: the next 20 years
JH Van Drie
Journal of computer-aided molecular design 21 (10), 591-601, 2007
1612007
Pharmacophore discovery-lessons learned
JH van Drie
Current pharmaceutical design 9 (20), 1649-1664, 2003
1502003
Approaches to virtual library design
JH Van Drie, MS Lajiness
Drug Discovery Today 3 (6), 274-283, 1998
1211998
Inhibitors of hepatitis C virus NS3· 4A protease 2. Warhead SAR and optimization
RB Perni, J Pitlik, SD Britt, JJ Court, LF Courtney, DD Deininger, ...
Bioorganic & Medicinal Chemistry Letters 14 (6), 1441-1446, 2004
962004
Assessing how well a modeling protocol captures a structure− activity landscape
R Guha, JH Van Drie
Journal of chemical information and modeling 48 (8), 1716-1728, 2008
842008
Bridged bicyclic serine protease inhibitors
LJ Farmer, J Pitlik, RB Perni, LF Courtney, J Van Drie
US Patent 6,909,000, 2005
712005
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
J Pitlik, KM Cottrell, LJ Farmer, RB Perni, LF Courtney, JH Van Drie, ...
US Patent 7,273,885, 2007
692007
Strategies for the determination of pharmacophoric 3D database queries
JHV Drie
Journal of computer-aided molecular design 11 (1), 39-52, 1997
661997
Inhibitors of hepatitis C virus NS3· 4A protease. Part 3: P2 proline variants
RB Perni, LJ Farmer, KM Cottrell, JJ Court, LF Courtney, DD Deininger, ...
Bioorganic & Medicinal Chemistry Letters 14 (8), 1939-1942, 2004
622004
Enhancement of binary QSAR analysis by a GA-based variable selection method
H Gao, MS Lajiness, J Van Drie
Journal of Molecular Graphics and Modelling 20 (4), 259-268, 2002
592002
Monty Kier and the origin of the pharmacophore concept
JH Van Drie
Internet Electronic Journal of Molecular Design 6 (9), 271-279, 2007
552007
Inhibitors of hepatitis C virus NS3· 4A protease 1. Non-Charged tetrapeptide variants
RB Perni, SD Britt, JC Court, LF Courtney, DD Deininger, LJ Farmer, ...
Bioorganic & Medicinal Chemistry Letters 13 (22), 4059-4063, 2003
532003
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
RB Perni, SD Britt, J Pitlik, JH Van Drie
US Patent 7,378,422, 2008
502008
Discovery of spiro oxazolidinediones as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases
MR Michaelides, A Kluge, M Patane, JH Van Drie, C Wang, TM Hansen, ...
ACS medicinal chemistry letters 9 (1), 28-33, 2018
462018
Protein folding, protein homeostasis, and cancer
JH Van Drie
Chinese journal of cancer 30 (2), 124, 2011
462011
The system can't perform the operation now. Try again later.
Articles 1–20